<DOC>
	<DOCNO>NCT02064179</DOCNO>
	<brief_summary>The use heparin aspirin respective anticoagulation antiplatelet effect routine intensive care unit around country world child undergone surgery congenital heart disease ( CHD ) risk thrombosis repair . Most common protocol recommend heparin infusion surgery transition oral aspirin oral intake begin . Patients risk thrombosis congenital heart surgery require long-term antiplatelet therapy include undergoing shunt placement single-ventricle palliation establishment pulmonary blood flow , valve replacement , coronary artery manipulation . Post-operative thrombosis congenital heart surgery rare , thrombosis result death . The routine use aspirin patient intend prevent potentially catastrophic consequence thrombosis . However , routine clinical assessment platelet inhibitory effect aspirin ; prospective study assess effectiveness aspirin 's antiplatelet effect child congenital heart surgery . No data exist suggest first dose aspirin transition heparin infusion either sufficient insufficient antiplatelet effect . In study , investigator evaluate effectiveness first aspirin dose antiplatelet effect surgery congenital heart disease . Degree antiplatelet effect evaluate thromboelastograph ( TEG ) TEG-platelet mapping study analysis . Thromboelastography clinical laboratory method assess whole blood hemostasis allow assessment clot formation , strength , stability . TEG commonly use patient risk bleed thrombosis also monitor antiplatelet therapy ( aspirin ) . The investigator hypothesize : first dose aspirin transition heparin infusion congenital heart surgery sufficient antiplatelet effect test TEG TEG-platelet mapping study . Confirmation antiplatelet effect aspirin help support current practice empiric aspirin therapy prevent post-operative thrombosis child congenital heart surgery .</brief_summary>
	<brief_title>Assessment Efficacy First Aspirin Dose Children Undergoing Surgery Congenital Heart Disease ( CHD ) Who Require Post-operative Antiplatelet Therapy</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Age 018 Undergoing surgery congenital heart disease require oral antiplatelet therapy Strict : personal family history bleeding/clotting disorder , patient require anticoagulation rather antiplatelet therapy surgery . Relative : patient significant postoperative bleeding precluding use anticoagulation and/or antiplatelet therapy within first 4872 hour ( eg . clinical instability prevent initiation oral aspirin therapy ) , patient require additional fresh platelet transfusion initiation postoperative heparin infusion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Congenital heart disease</keyword>
	<keyword>Antiplatelet therapy</keyword>
	<keyword>Aspirin</keyword>
</DOC>